With more generic pharmaceuticals hitting the market, the glucagon-like peptide 1 (GLP-1) agonists market is expected to develop in the region
If any of that sounds familiar, youre not being dramatic, and youre not alone
(All committee members underwent the same ethics review and vetting process required of all FDA advisory committee members, Emily Hilliard, a spokesperson for the Department of Health and Human Services, told me in an email.) The decision is only a recommendation, and the FDA would still need to sign off on an actual rule change
For example, this includes navigating racialized beauty standards in Brazil and technologies of neoliberal self-discipline in the US
But now pharma is racing to build drugs to fix the muscle loss caused by the drugs
In theory, a protocol incorporating both peptides simultaneously could engage a broader range of repair mechanisms than either compound alone, covering cell migration, angiogenesis, inflammation modulation, and tissue remodelling in a single intervention